Key Points
- Proto Labs insider Michael Kenison sold 200 shares on May 7 at $70 each, totaling $14,000. The sale was made under a pre-arranged Rule 10b5-1 trading plan.
- The company reported stronger-than-expected quarterly results, posting EPS of $0.54 versus estimates of $0.40 and revenue of $139.34 million versus $135.31 million expected. Revenue rose 10.4% year over year.
- Wall Street sentiment remains mixed but constructive, with three Buy ratings and two Hold ratings, and a current average analyst rating of “Moderate Buy.” The average price target is $53.33.
Proto Labs, Inc. (NYSE:PRLB - Get Free Report) insider Michael Kenison sold 200 shares of the firm's stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $70.00, for a total value of $14,000.00. Following the transaction, the insider owned 27,186 shares in the company, valued at $1,903,020. The trade was a 0.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Proto Labs Stock Up 1.4%
PRLB opened at $69.12 on Friday. The stock's fifty day moving average is $60.55 and its two-hundred day moving average is $56.28. The company has a market capitalization of $1.64 billion, a P/E ratio of 65.21 and a beta of 1.36. Proto Labs, Inc. has a 52 week low of $36.15 and a 52 week high of $70.00.
Proto Labs (NYSE:PRLB - Get Free Report) last announced its earnings results on Friday, May 1st. The industrial products company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.14. The business had revenue of $139.34 million for the quarter, compared to analysts' expectations of $135.31 million. Proto Labs had a return on equity of 4.15% and a net margin of 4.71%.The business's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.33 EPS. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. Equities analysts anticipate that Proto Labs, Inc. will post 1.37 earnings per share for the current year.
Institutional Trading of Proto Labs
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Disciplined Growth Investors Inc. MN lifted its position in Proto Labs by 1.9% during the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 2,722,011 shares of the industrial products company's stock worth $108,989,000 after acquiring an additional 51,293 shares during the period. Rubric Capital Management LP lifted its position in Proto Labs by 8.6% during the 3rd quarter. Rubric Capital Management LP now owns 1,123,338 shares of the industrial products company's stock worth $56,201,000 after acquiring an additional 89,167 shares during the period. American Capital Management Inc. lifted its position in Proto Labs by 126.0% during the 4th quarter. American Capital Management Inc. now owns 631,311 shares of the industrial products company's stock worth $31,938,000 after acquiring an additional 352,015 shares during the period. Arrowstreet Capital Limited Partnership lifted its position in Proto Labs by 3.0% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 460,618 shares of the industrial products company's stock worth $23,045,000 after acquiring an additional 13,488 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in Proto Labs by 9.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 363,013 shares of the industrial products company's stock worth $18,365,000 after acquiring an additional 31,585 shares during the period. Institutional investors and hedge funds own 84.54% of the company's stock.
Wall Street Analyst Weigh In
Several brokerages have issued reports on PRLB. Weiss Ratings raised Proto Labs from a "hold (c)" rating to a "hold (c+)" rating in a research report on Wednesday. Zacks Research cut Proto Labs from a "strong-buy" rating to a "hold" rating in a research report on Friday, April 10th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, Proto Labs currently has an average rating of "Moderate Buy" and an average price target of $53.33.
Read Our Latest Report on Proto Labs
About Proto Labs
(
Get Free Report)
Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.
Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
